Skip to main content

NCT01193153 - A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder

A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder


Data Specification

Not Available


Annotated CRF

Available upon data request approval

Product Info

Generic Name
Paliperidone palmitate
Product Name
INVEGA SUSTENNA®
Therapeutic Area
Behaviors and Mental Disorders
Enrollment
667
% Female
46.5%
% White
53.1%
Product Class
Atypical Antipsychotics
Sponsor Protocol Number
R092670SCA3004
Data Partner
Johnson & Johnson
Condition Studied
Schizoaffective Disorder
Mean/Median Age (Years)
39.5

Supporting Documentation

Clinical Study Report
Collected Datasets
Annotated Case Report Form
Protocol with Amendments
Statistical Analysis Plan
Study Phase 
3

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.